In normal times, VIR’s HBV data would’ve been a hot topic, but my tweet on the dataset (and the planned use of peg-IFN in the follow-up trial) went almost unnoticed.
“The efficient-market hypothesis may be the foremost piece of B.S. ever promulgated in any area of human knowledge!”